Form 4: Olaplex Executive Kristi Belhumeur Reports Stock Sale and RSU Grant

Sentiment:

SEC Form 4 Filing


Kristi Belhumeur, Senior VP of Accounting at Olaplex Holdings, Inc., reports the sale of 42,480 shares of common stock and the acquisition of 62,112 restricted stock units.

Summary

  • Kristi Belhumeur, Senior VP of Accounting at Olaplex Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On May 3, 2024, Belhumeur sold 42,480 shares of common stock at a weighted average price of $1.68 per share.
  • The sale price ranged from $1.67 to $1.70.
  • On May 6, 2024, Belhumeur acquired 62,112 restricted stock units (RSUs) under the company's 2021 Equity Incentive Plan.
  • These RSUs will vest on April 4, 2026, contingent upon continued employment.
  • Following these transactions, Belhumeur beneficially owns 356,665 shares of Olaplex common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued employment with the Issuer through April 4, 2026.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
  • Companies like L'Oreal, Unilever, and Procter & Gamble also have executives who regularly file similar forms related to their company stock.

Stakeholder Impact

  • The stock sale by an executive could be perceived negatively by some shareholders, while others may see it as a normal part of executive compensation and portfolio management.
  • The grant of RSUs aligns the executive's interests with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.

Key Dates

DateDescription
05/03/2024Sale of 42,480 shares of common stock.
05/06/2024Acquisition of 62,112 restricted stock units (RSUs).
04/04/2026Vesting date for the acquired RSUs.
05/07/2024Date of the signature on the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.